Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA), umeclidinium bromide (UMEC), with a LABA, and VI; and TRELEGY ELLIPTA, a once-daily combination medicine consisting of an ICS, LAMA, and LABA. Innoviva, Inc. has a strategic partnership with Sarissa Capital Management LP. The company has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California.
Over the last 12 months, insiders at Innoviva, Inc. have bought $0 and sold $153,810 worth of Innoviva, Inc. stock.
On average, over the past 5 years, insiders at Innoviva, Inc. have bought $4.38M and sold $98.08M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 62,000 shares for transaction amount of $814,196 was made by DENNER ALEXANDER J (10 percent owner) on 2023‑06‑15.
2023-11-15 | Sale | Zhen Marianne | Chief Accounting Officer | 10,994 0.0173% | $13.99 | $153,810 | +11.81% | |
2023-06-15 | DENNER ALEXANDER J | 10 percent owner | 62,000 0.0912% | $13.13 | $814,196 | +11.20% | ||
2023-06-06 | DENNER ALEXANDER J | 10 percent owner | 8,000 0.0118% | $13.05 | $104,384 | +10.38% | ||
2023-06-05 | DENNER ALEXANDER J | 10 percent owner | 7,000 0.0102% | $13.04 | $91,297 | +9.09% | ||
2023-05-30 | DENNER ALEXANDER J | 10 percent owner | 120,000 0.1775% | $13.01 | $1.56M | +7.09% | ||
2023-05-26 | DENNER ALEXANDER J | 10 percent owner | 30,000 0.0442% | $13.12 | $393,729 | +5.71% | ||
2023-05-25 | DENNER ALEXANDER J | 10 percent owner | 50,000 0.0735% | $13.09 | $654,330 | +5.62% | ||
2023-05-19 | DENNER ALEXANDER J | 10 percent owner | 36,000 0.0531% | $13.48 | $485,147 | +1.71% | ||
2023-05-18 | DENNER ALEXANDER J | 10 percent owner | 10,000 0.0146% | $13.05 | $130,538 | +3.77% | ||
2023-05-17 | DENNER ALEXANDER J | 10 percent owner | 50,000 0.0736% | $13.07 | $653,690 | +4.46% | ||
2023-05-11 | DENNER ALEXANDER J | 10 percent owner | 290,000 0.4246% | $12.34 | $3.58M | +9.90% | ||
2023-03-10 | Raifeld Pavel | Chief Executive Officer | 3,000 0.0045% | $10.87 | $32,603 | +22.61% | ||
2021-08-20 | Sale | Zhen Marianne | Chief Accounting Officer | 1,129 0.0016% | $15.89 | $17,940 | +3.07% | |
2021-08-19 | Sale | Zhen Marianne | Chief Accounting Officer | 2,802 0.004% | $16.02 | $44,888 | +2.50% | |
2021-05-24 | Bickerstaff George | director | 10,000 0.0112% | $13.46 | $134,619 | +21.34% | ||
2021-05-21 | Bickerstaff George | director | 10,000 0.0111% | $12.97 | $129,670 | +24.75% | ||
2021-05-20 | Sale | GLAXOSMITHKLINE PLC | 10 percent owner | 32.01M 33.288% | $12.25 | $392.06M | +23.35% | |
2020-02-24 | Sale | Zhen Marianne | Chief Accounting Officer | 2,954 0.003% | $14.78 | $43,660 | -14.60% | |
2019-02-27 | Bickerstaff George | director | 15,000 0.0148% | $15.90 | $238,500 | -13.22% | ||
2019-02-26 | Sale | Zhen Marianne | Chief Accounting Officer | 5,617 0.0055% | $16.00 | $89,872 | -13.92% |
Zhen Marianne | Chief Accounting Officer | 40158 0.0627% | $16.28 | 0 | 5 | |
DENNER ALEXANDER J | 10 percent owner | 7277000 11.3549% | $16.28 | 10 | 0 | +6.89% |
Aguiar Michael W | President & Chief Exec Officer | 980907 1.5306% | $16.28 | 0 | 9 | |
Winningham Rick E | Chief Executive Officer | 690106 1.0768% | $16.28 | 1 | 10 | +19.65% |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 446274 0.6964% | $16.28 | 1 | 9 | <0.0001% |
dEsparbes Eric | SVP and CFO | 373081 0.5822% | $16.28 | 0 | 9 | |
ABERCROMBIE GEORGE B | Sr. VP & Chief Comm. Officer | 285479 0.4455% | $16.28 | 0 | 4 | |
GLICK MARTY | Executive VP, Finance and CFO | 267805 0.4179% | $16.28 | 1 | 0 | <0.0001% |
Witek Theodore J. Jr. | Sr. VP & Chief Scientific Off. | 247767 0.3866% | $16.28 | 0 | 5 | |
Mammen Mathai | SVP, Research & Early Clin Dev | 211705 0.3303% | $16.28 | 0 | 7 | |
BLUM LEONARD M | Sr VP, Chief Comm. Officer | 158618 0.2475% | $16.28 | 3 | 0 | +41.56% |
Bickerstaff George | director | 124560 0.1944% | $16.28 | 4 | 0 | +6.52% |
WALTRIP WILLIAM H | director | 123604 0.1929% | $16.28 | 0 | 1 | |
VAGELOS P ROY | director | 71499 0.1116% | $16.28 | 2 | 0 | +22.32% |
Tyree James L | director | 50697 0.0791% | $16.28 | 0 | 2 | |
Brinkley David L | Head of Business Dev. | 48749 0.0761% | $16.28 | 0 | 20 | |
YOUNG WILLIAM D | director | 34129 0.0533% | $16.28 | 0 | 3 | |
DRAZAN JEFFREY M | director | 33465 0.0522% | $16.28 | 0 | 4 | |
Kitt Michael | Sr. Vice President Development | 30738 0.048% | $16.28 | 0 | 5 | |
Humphrey Patrick PA | Executive VP Research | 11000 0.0172% | $16.28 | 1 | 0 | <0.0001% |
Raifeld Pavel | Chief Executive Officer | 9799 0.0153% | $16.28 | 1 | 0 | +22.61% |
HULME GEOFFREY | Interim PEO | 7000 0.0109% | $16.28 | 1 | 0 | <0.0001% |
Sturmer A Gregory | Vice President Finance | 290 0.0005% | $16.28 | 1 | 0 | <0.0001% |
BAKER JULIAN | director | 0 0% | $16.28 | 0 | 1 | |
Loewenthal Ronn | director | 0 0% | $16.28 | 0 | 1 | |
GLAXOSMITHKLINE PLC | 10 percent owner | 0 0% | $16.28 | 9 | 1 | +1.07% |
BlackRock | $154.57M | 16.24 | 10.14M | -2.03% | -$3.2M | <0.01 | |
Sarissa Capital Management LP | $110.9M | 11.65 | 7.28M | 0% | +$0 | 19.4 | |
The Vanguard Group | $95.8M | 10.07 | 6.29M | -6.35% | -$6.5M | <0.01 | |
Franklin Templeton Investments | $95.58M | 10.04 | 6.27M | +13,628.29% | +$94.88M | 0.03 | |
Dimensional Fund Advisors | $70.31M | 7.39 | 4.61M | +2.13% | +$1.47M | 0.02 | |
Renaissance Technologies | $66.53M | 6.99 | 4.37M | +5.33% | +$3.37M | 0.11 | |
Pacer Advisors Inc | $51.22M | 5.38 | 3.36M | +94.38% | +$24.87M | 0.13 | |
State Street | $38.19M | 4.01 | 2.51M | -0.51% | -$194,843.40 | <0.01 | |
Westfield Capital Management Co Lp | $32.18M | 3.38 | 2.11M | -19.22% | -$7.66M | 0.17 | |
Systematic Financial Management LLC | $31.6M | 3.32 | 2.07M | -4.27% | -$1.41M | 0.89 | |
Geode Capital Management | $20.2M | 2.12 | 1.33M | +1.08% | +$215,841.75 | <0.01 | |
Invesco | $19.25M | 2.02 | 1.26M | +9.39% | +$1.65M | <0.01 | |
Morgan Stanley | $17.99M | 1.89 | 1.18M | -44.25% | -$14.28M | <0.01 | |
Charles Schwab | $14.15M | 1.49 | 928,663 | -0.49% | -$70,043.04 | <0.01 | |
Bank of America | $13.94M | 1.47 | 914,665 | +14.75% | +$1.79M | <0.01 | |
Goldman Sachs | $13.23M | 1.39 | 868,210 | -15.84% | -$2.49M | <0.01 | |
Assenagon Asset Management S.A. | $12.35M | 1.3 | 810,208 | 0% | +$0 | 0.03 | |
D. E. Shaw & Co. | $11.2M | 1.18 | 734,730 | -4.71% | -$553,029.11 | 0.02 | |
Deutsche Bank | $10.81M | 1.14 | 709,501 | -1.39% | -$152,460.96 | 0.01 | |
Northern Trust | $10.37M | 1.09 | 680,294 | -5.67% | -$622,995.93 | <0.01 | |
Russell Investments Group Ltd | $8.54M | 0.9 | 560,444 | -35.53% | -$4.71M | 0.01 | |
BNY Mellon | $8.47M | 0.89 | 555,781 | -6.29% | -$568,314.68 | <0.01 | |
Two Sigma | $8.37M | 0.88 | 549,226 | +48.07% | +$2.72M | 0.01 | |
UBS | $8.26M | 0.87 | 542,296 | +51.62% | +$2.81M | <0.01 | |
Bridgeway Capital Management | $8.21M | 0.86 | 539,016 | +3.63% | +$287,883.61 | 0.15 | |
Robeco Institutional Asset Management B.V. | $7.2M | 0.76 | 472,277 | -1.91% | -$140,482.31 | 0.02 | |
Arrowstreet Capital, Limited Partnership | $7.07M | 0.74 | 464,037 | +99.83% | +$3.53M | 0.01 | |
Man Group Plc | $6.25M | 0.66 | 410,337 | +8.44% | +$486,476.05 | 0.02 | |
Two Sigma Advisers LP | $6.19M | 0.65 | 406,100 | +92.46% | +$2.97M | 0.01 | |
Nuveen | $5.99M | 0.63 | 393,348 | -18.67% | -$1.38M | <0.01 | |
Boston Partners | $5.97M | 0.63 | 391,456 | +90.33% | +$2.83M | 0.01 | |
Denali Advisors | $4.97M | 0.52 | 326,086 | -0.94% | -$47,244.00 | 1.47 | |
Hillsdale Investment Management Inc. | $4.81M | 0.51 | 315,600 | +8.57% | +$379,476.00 | 0.4 | |
ExodusPoint Capital Management, LP | $4.33M | 0.46 | 284,215 | New | +$4.33M | 0.05 | |
Empowered Funds Llc | $3.81M | 0.4 | 249,826 | +8.18% | +$287,883.58 | 0.07 | |
Redwood Investment Management, LLC | $3.25M | 0.34 | 213,533 | +6.43% | +$196,748.95 | 0.38 | |
RhumbLine Advisers | $3.17M | 0.33 | 208,107 | -0.21% | -$6,537.91 | <0.01 | |
Uniplan Investment Counsel Inc | $2.85M | 0.3 | 186,708 | +0.79% | +$22,262.28 | 0.23 | |
Comerica | $2.81M | 0.3 | 184,142 | -29.6% | -$1.18M | 0.01 | |
Ameriprise Financial | $2.81M | 0.3 | 184,419 | -3.03% | -$87,767.14 | <0.01 | |
Cwa Asset Management Group Llc | $2.73M | 0.29 | 179,403 | -29.3% | -$1.13M | 0.17 | |
AQR Capital | $2.68M | 0.28 | 175,753 | -11.84% | -$359,618.18 | 0.01 | |
Exchange Traded Concepts, LLC | $2.68M | 0.28 | 175,683 | +10.78% | +$260,558.29 | 0.06 | |
Jane Street Capital | $2.62M | 0.28 | 172,213 | +1,058.2% | +$2.4M | <0.01 | |
Hussman Strategic Advisors Inc | $2.56M | 0.27 | 168,000 | +60% | +$960,120.00 | 0.6 | |
Legal & General | $2.5M | 0.26 | 163,742 | +0.12% | +$3,002.28 | <0.01 | |
State of Wisconsin Investment Board | $2.49M | 0.26 | 163,177 | +42.43% | +$740,831.50 | 0.01 | |
New York State Common Retirement Fund | $2.29M | 0.24 | 150,400 | -1.19% | -$27,598.48 | <0.01 | |
GENWORTH FINANCIAL WEALTH MANAGEMENT INC | $2.15M | 0.23 | 140,967 | +147.57% | +$1.28M | 0.01 | |
JPMorgan Chase | $2.09M | 0.22 | 137,359 | -58.28% | -$2.92M | <0.0001 |